<?xml version="1.0" encoding="UTF-8"?>
<ref id="B70">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Monteil</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Prado</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Hagelkrüys</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wimmer</surname>
    <given-names>R. A.</given-names>
   </name>
   <name>
    <surname>Stahl</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2</article-title>. 
  <source>Cell</source>
  <volume>181</volume> (
  <issue>4</issue>), 
  <fpage>905</fpage>–
  <lpage>913.e7</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.cell.2020.04.004</pub-id>
  <pub-id pub-id-type="pmid">32333836</pub-id>
 </mixed-citation>
</ref>
